|
|
 |
| Àâòîðèçàöèÿ |
|
|
|
| Ïîèñê ïî óêàçàòåëÿì |
|
|
|
|
|
|
|
 |
|
|
|
| Lanza R. (ed.), Weissman I. (ed.), Thomson J. (ed.) — Handbook of Stem Cells (vol. 1) Embryonic Stem Cells |
|
|
|
| Ïðåäìåòíûé óêàçàòåëü |
Immunoglobulins in B cell development 2: 96 2:
Immunoglobulins, heavy chain gene intron enhancer 2: 98—100 2:
Imprinting 1: 79—81 1:
Imprinting in oocytes 1: 659
Imprinting, alterations during culture 1: 123
Imprinting, control region 1: 80
Imprinting, EG cells 1: 190—191
Imprinting, histone hypoacetylation and 2: 107
Imprinting, primordial germ cells 1: 190
Incubators 1: 437—438
Indian hedgehog in cardiomyogenesis 1: 305
Indian hedgehog to enhance hematopoiesis 1: 282
Indian hedgehog, function 1: 282
Indocyanine Green 1: 362
Infection as bone marrow transplantation complication 2: 368—369
Infection, cell fusion in 2: 153
Infection, screening of donor tissues in stem cell therapy 1: 778—779
Infection, skin transplantation risk 2: 765
Infrapatellar fat pad 2: 435—436
Inner cell mass (ICM) 1: 27 1: 1:
Inner cell mass (ICM) in epiblast formation 1: 131
Inner cell mass (ICM), blastocyst cells 1: 642
Inner cell mass (ICM), during implantation 1: 149—151
Inner cell mass (ICM), formation 1: 129 1:
Inner cell mass (ICM), outgrowth 1: 443f
Inner cell mass (ICM), outgrowth, defects 1: 49
Inner cell mass (ICM), pluripotent cells 1: 45
Inner cell mass (ICM), preimplantation development 1: 148—149
Inner cell mass (ICM), trophoblast development 1: 193 1:
Insulin-like growth factor in cardiac stem cell mobilization 2: 715 2:
Insulin-like growth factor in neurogenesis 2: 220—221
Insulin-like growth factor, muscle stem cell secretion 2: 399
Insulin-producing cells 2: 150
Insulin-producing cells, ES cell-derived 1: 723—727
Insulin-producing cells, precursor cells 2: 732—734
Insulin-producing cells, sources 2: 731 2:
Integrated Dual-Use Commercial Companies 1: 797
Integrins 2: 65 2: 2:
Integrins as epidermal stem cell marker 2: 248—249 2:
Integrins in epidermal stem cell differentiation 2: 250
Integrins, hematopoietic stem cell regulation 2: 339
Integrins, human ES cell expression 1: 408
Intellectual property issues 1: 793—798
Interferons 1: 664—665 2:
Interleukin-10 2: 748
Interleukin-13 deficient mice 1: 591—592
Interleukin-2 2: 748
Interleukin-2, age-related changes 2: 749
Interleukin-20 2: 183
Interleukin-3 deficient mice 1: 591—592
Interleukin-3, overriding cell cycle checkpoints 2: 120—121
Interleukin-4 1: 591
Interleukin-4 deficient mice 1: 592—593 1:
Interleukin-5 deficient mice 1: 591
Interleukin-5 in eosinophil recruitment 1: 591
Interleukin-5, function 1: 591
Interleukin-6 1: 28
Interleukin-6, ES cell receptor binding 1: 28—29
Interleukin-6, JAK-STAT signaling pathway and 1: 174—175
Interleukin-6, signaling pathways 1: 31—33 1:
Interleukin-7 2: 754
Interleukin-7 in lymphocyte development 2: 95—96 2: 2: 2:
Interleukin-7, common lymphoid progenitors 2: 348—349 2:
Interleukin-8 2: 595—596
Interstitial cells of hydra 2: 52—55
Interstitial cells, differentiation 2: 53—55
Interstitial cells, potency 2: 52—53
Intestinal subepithelial myofibroblasts 2: 522 2:
Intraepithelial lymphocytes 2: 747
Intron enhancer 2: 98—100 2:
Intronic asymmetric enhancer 1: 136
Introns, interruption 1: 593
Introns, recombinase target insertion 1: 614
Islet cells 2: 513
Islet cells in thymus epithelial cells 2: 561
Islet cells,  -cells and non-P-cells in 1: 726—727
Islet cells, adult pancreatic progenitor cells 2: 516—517
Islet cells, ES cell-derived 1: 506—507
Islet cells, generation of 1: 724—725
Islet cells, insulin content 1: 725
Islet cells, medullary 2: 561
Islet cells, neogenesis 2: 732—733 2:
Islet cells, Nestin expression 1: 507
Islet cells, origin 2: 559—560
Islet cells, thymus development 2: 559
Islet cells, transdifferentiation of non-islet cells to 2: 733—734
Islet cells, transplantation 1: 723 (see also “Pancreatic -cells” “Pancreatic
Jak kinases in ES cell self-renewal 1: 131—132
Jak kinases in germ line stem cell self-renewal 1: 173—175
Jak kinases in hematopoietic stem cell self-renewal 2: 313
Jak kinases, Drosophila stem cell fate signaling 2: 61—62
Jak kinases, signal transduction 1: 30
Jun-N terminal kinase in cardiomyogenesis 1: 307
JunB in ES cell cycle regulation 1: 58
Juvenile Diabetes Research Foundation 1: 800—803
Karyotype, human ES cell 1: 408
Keratinocyte cells 2: 245 2:
Keratinocyte cells, clonogenicity 2: 246—247
Keratinocyte cells, function 2: 761
Keratinocyte cells, integrin labeling 2: 248—249
Keratinocyte stem cells 1: 731—732
Keratinocyte stem cells, aging effects 2: 763
Keratinocyte stem cells, clonal analysis 2: 762—763 2:
Keratinocyte stem cells, clonal conversion 2: 762f 2:
Keratinocyte stem cells, differentiation 2: 67
Keratinocyte stem cells, epidermis regeneration from 2: 761 2:
Keratinocyte stem cells, function 2: 761
Keratinocyte stem cells, growth capacity 2: 762
Keratinocyte stem cells, potency 2: 761—762
Keratinocyte stem cells, skin graft cultivation 2: 762 2:
Keratinocyte stem cells, skin transplantation technique 2: 765
Keratinocyte stem cells, therapeutic potential 2: 768
Keratinocyte stem cells, xenotransplantation 2: 764
Kidney, adult stem cells in 2: 478—479
Kidney, anatomy 1: 335—337
Kidney, artificial renal tubule 2: 480
Kidney, development 2: 478
Kidney, development, cell lineages 1: 342f
Kidney, development, endothelial cells in 1: 342
Kidney, development, epithelial cell differentiation in 1: 340—341 1:
Kidney, development, genetic pathway analysis 1: 584—585
Kidney, development, glomerular architecture 1: 341—342
Kidney, development, metanephric mesenchyme induction 1: 336—337 1: 1:
Kidney, development, nephric duct 1: 335—336 1: 1:
Kidney, development, regulatory mechanisms 1: 338—340 1:
Kidney, development, renal stem cell 1: 1: 342—343
Kidney, development, stromal cells in 1: 340—341
Kidney, development, ureteric bud 1: 336—337 1: 1:
Kidney, development, Xenopus model 1: 485 1:
Kidney, regeneration as injury response 2: 477—478
Kidney, stem cell differentiation in 2: 475—477
Kidney, therapeutic interventions 2: 479—480
Kit-ligand 2: 381—382
Knee injuries/disorders 2: 435—436 2:
Lab equipment 1: 437—438
Label-retaining cells 2: 259—260
Labeling techniques 1: 545—546
Lac operon 1: 594—595 1:
lacO/lacI system 1: 595—597
LacZ tagging 1: 575 1:
Laminin, human ES cell expression 1: 408
Larynx development 1: 379
Lef1 2: 66 2:
Lef1 in skin development 2: 263
Legal issues 1: 759 1:
Legal issues, research see also “Regulation of stem cell research”
Lentiviruses 2: 657—658
Lentiviruses, ES cell transduction by 1: 613
Lentiviruses, ES cell transduction by vector design 1: 557—559
Lentiviruses, ES cell transduction by virus characteristics 1: 557
| Lesch — Nyhan syndrome 1: 546 1:
Leukemia 2: 89
Leukemia inhibitory factor 1: 18 1:
Leukemia inhibitory factor in differentiation of ES cells in adipocytes 1: 329 1:
Leukemia inhibitory factor in ES cell pluripotency 1: 38
Leukemia inhibitory factor in ES cell self-renewal 1: 45 1: 1: 1: lit
Leukemia inhibitory factor in ES/ESL culturing 1: 20
Leukemia inhibitory factor in gp30/gpl30 dimerization 1: 28—29
Leukemia inhibitory factor in hepatic stem cell activation 2: 504—505
Leukemia inhibitory factor in preimplantation development 1: 146—148
Leukemia inhibitory factor in primordial germ cell proliferation 1: 451 1:
Leukemia inhibitory factor, culturing human ES cells 1: 438 1: 1:
Leukemia inhibitory factor, function 1: 28
Leukemia inhibitory factor, human ES cell response 1: 407
Leukemia inhibitory factor, signal mediation 1: 626
Leukemia inhibitory factor, STAT protein interaction 1: 30—31
Leukemia, acute myelocytic 2: 687
Leukemia, chronic myeloid 1: 280 2: 2:
Leukemia, hematopoietic stem cell transformation in 2: 315—316
Leydig cells 1: 350—351
Library, mutagenized cell 1: 602—603 1:
Ligaments, injury response 2: 775—776
Ligaments, periodontal 2: 280 2:
Ligaments, structure and function 2: 776
Ligaments, tissue engineering 2: 776
Limiting dilution 2: 14
Liml gene 1: 585
Lineage marking 1: 573—578
Lipoprotein lipase 2: 429
Liver 1: 115
Liver, adult stem cells 2: 483—491
Liver, anatomy 2: 483
Liver, bioartificial systems 1: 359
Liver, cell specification 1: 360
Liver, cell types 2: 483
Liver, development 1: 360 2:
Liver, disorders 1: 359
Liver, function 1: 359 2:
Liver, hematopoiesis development 2: 166—167
Liver, hepatocyte progenitors 2: 485—486
Liver, hepatocyte-derived pancreatic cells 2: 140—141
Liver, hepatocytes formed from pancreatic cell line 2: 139—140 2:
Liver, nonhepatocyte progenitors 2: 487—41—90
Liver, pancreatic heterotopia 2: 140—141
Liver, precursors of insulin-producing cells in 2: 734
Liver, regenerative capacity 2: 483—486 2:
Liver, regenerative mechanisms 2: 497—498 2:
Liver, transplantation therapies 1: 359—360 (see also “Hepatic stem cells”)
Long-term repopulating stem cells 1: 94
Lung biology and function 2: 547—549
Lung biology and function, airway stem cell phenotype 2: 552—553
Lung development, alveolarization 1: 383—384
Lung development, cell types 1: 379 1: 1:
Lung development, cell types, functional diversity 1: 384
Lung development, early patterning of foregut endoderm 1: 379—381
Lung development, injury response 1: 379
Lung development, injury response, after resection/transplantation 1: 385—386
Lung development, injury response, emphysema 1: 386
Lung development, injury response, evidence for lung stem cell 1: 384—385
Lung development, injury response, multipotent adult progenitor cell engraftment 1: 386—387
Lung development, morphogenesis 1: 379 1:
Lung development, progenitor cells 1: 379 1: 1:
Lung development, respiratory tubules 1: 383
Lung development, stem cell niches in 1: 385 1:
Lung development, structural origins of components 1: 380f
Lung development, transcriptional control 1: 383
Lung stem cells 1: 384—385
Lung stem cells, adult 2: 547—553
Lung stem cells, epithelial reconstitution studies of progenitor-progeny relationships 2: 549—551
Lung stem cells, injury models to study niche mobilization of 2: 551—552
Lymphangiomyomatosis 1: 387
Lymphatic vascular system 2: 467—469
Lymphocyte progenitor cells 1: 398—399
Lymphocytes 2: 95
Lymphocytes, age-related changes 2: 749 2: “T
Lymphopoiesis, age-related changes 2: 754
Lymphopoiesis, common lymphoid progenitors in 2: 356—358
Lymphopoiesis, functional assays 2: 349
Macrophage colony-stimulating factor in osteoclast development 1: 295—296 1:
Macrophages, nuclear transfer cloning from 1: 644
Macrophages, origins and development 2: 162
Macular degeneration 1: 257
Magnetic selection techniques 2: 610—611 2:
Major histocompatibility complex 1: 664—667 1: 1:
Major histocompatibility complex, knockouts 1: 670—671
Major histocompatibility complex, T cell interactions 1: 678
Mammary epithelium 2: 269—276
Mammary epithelium in carcinogenesis 2: 274—275
Mammary epithelium, aging effects 2: 269—270
Mammary epithelium, cell markers 2: 272—274
Mammary epithelium, cell types 2: 272—273
Mammary epithelium, future research 2: 275—276
Mammary epithelium, pregnancy response 2: 275
Mammary epithelium, regenerative capacity 2: 269—272
Mammary epithelium, small light cells in 2: 272 2:
Mammary epithelium, stem cells 2: 269
Mammary gland 2: 269
Manufacturing of stem cell products 2: 806—811
MAPKs see “Mitogen-activated protein kinases”
Marfan’s syndrome 2: 791
Marrow stromal cells see “Mesenchymal stem cells”
Mash 1 gene 2: 236—237
Master cell bank 2: 808—809
Mathl gene 2: 199 2: 2:
Matrix metalloproteinases 2: 599
Matrix metalloproteinases in proangiogenic stem cell recruitment 2: 380—383 2:
Maturation promoting factor 1: 124
Maxillofacial cartilage 1: 489—490
Megakaryocyte-erythrocyte-restricted progenitors 2: 355 2:
Megakaryocytes 2: 161
Meiotic sex chromosome inactivation 1: 75
Melanoblast self-renewal 1: 234—235
Melanocytes 2: 761
Melanocytes, culturing, from ES cells 1: 233—235
Melanocytes, development 1: 233
Melanoma therapy 2: 742
Meniscus repair 2: 775
Merkel cells 2: 761
Meroclones 2: 246—247 2:
Mesenchymal stem cells 2: 299—305
Mesenchymal stem cells in bone marrow 2: 723 2:
Mesenchymal stem cells in bone regeneration 2: 772—773
Mesenchymal stem cells in cartilage repair 2: 773—775
Mesenchymal stem cells in chondrogenesis 2: 434—435
Mesenchymal stem cells in ligament and tendon repair 2: 776—777
Mesenchymal stem cells in meniscal tissue engineering 2: 775
Mesenchymal stem cells in osteogenesis 2: 431—432 2:
Mesenchymal stem cells in spine repair 2: 777—778
Mesenchymal stem cells, aging effects 2: 301—302
Mesenchymal stem cells, clinical significance 2: 791
Mesenchymal stem cells, culturing 2: 302
Mesenchymal stem cells, definition and characteristics 2: 13
Mesenchymal stem cells, dental 1: 268—270 2:
Mesenchymal stem cells, distribution 2: 301
Mesenchymal stem cells, early research 2: 299—301
Mesenchymal stem cells, expansion cultures 2: 663 2: 2:
Mesenchymal stem cells, markers 2: 301
Mesenchymal stem cells, myogenic potential 2: 723
Mesenchymal stem cells, plasticity 2: 84 2:
Mesenchymal stem cells, processed lipoaspirate cells and 2: 426f 2:
Mesenchymal stem cells, tissue engineering applications 2: 302—305 2: 2:
Mesenchyme in early hematopoietic development 2: 163—165
Mesenchyme in thymus and parathyroid development 1: 396 2:
Mesoangioblasts in muscular dystrophy treatment 2: 724
Mesoangioblasts, characteristics 2: 723—724
Mesoderm 1: 371
Mesoderm, cardiac 1: 276 1:
Mesoderm, cranial 1: 276
Mesoderm, embryonic 1: 276
Mesoderm, extraembryonic 1: 275—276
|
|
|
| Ðåêëàìà |
|
|
|
|
|
Î ïðîåêòå